CM101 is an anti-pathoangiogenic polysaccharide that can be derived from group B streptococcus. CM101 can inhibit inflammatory angiogenesis and accelerate wound healing in mouse models as well as minimizing scarring after spinal cord injury. CM101 also causes rapid tumor neovascularitis, infiltration of inflammatory cells, inhibition of tumor growth and tumor apoptosis[1][2].
CAS Nummer:
[2244739-55-5]
Target-Kategorie:
Apoptosis
Anwendungsbeschreibung:
Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
